HRP20170171T1 - Postupak za proizvodnju isavukonazola ili ravukonazola - Google Patents

Postupak za proizvodnju isavukonazola ili ravukonazola

Info

Publication number
HRP20170171T1
HRP20170171T1 HRP20170171TT HRP20170171T HRP20170171T1 HR P20170171 T1 HRP20170171 T1 HR P20170171T1 HR P20170171T T HRP20170171T T HR P20170171TT HR P20170171 T HRP20170171 T HR P20170171T HR P20170171 T1 HRP20170171 T1 HR P20170171T1
Authority
HR
Croatia
Prior art keywords
isavuconazole
ravuconazole
procedure
production
Prior art date
Application number
HRP20170171TT
Other languages
English (en)
Croatian (hr)
Inventor
Ruben Van Summeren
Harrie VAESSEN
Daniel Mink
Mario Waser
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of HRP20170171T1 publication Critical patent/HRP20170171T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Enzymes And Modification Thereof (AREA)
HRP20170171TT 2012-08-07 2013-07-31 Postupak za proizvodnju isavukonazola ili ravukonazola HRP20170171T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12179540 2012-08-07
EP13747999.4A EP2882723B1 (en) 2012-08-07 2013-07-31 Process for the manufacture of isavuconazole or ravuconazole
PCT/EP2013/066071 WO2014023623A1 (en) 2012-08-07 2013-07-31 Process for the manufacture of isavuconazole or ravuconazole

Publications (1)

Publication Number Publication Date
HRP20170171T1 true HRP20170171T1 (hr) 2017-04-07

Family

ID=48979725

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170171TT HRP20170171T1 (hr) 2012-08-07 2013-07-31 Postupak za proizvodnju isavukonazola ili ravukonazola

Country Status (15)

Country Link
US (2) US9783508B2 (enExample)
EP (1) EP2882723B1 (enExample)
JP (1) JP6334529B2 (enExample)
KR (1) KR102129150B1 (enExample)
CN (1) CN104507917B (enExample)
BR (1) BR112015002526B1 (enExample)
CA (1) CA2878361C (enExample)
ES (1) ES2616412T3 (enExample)
HR (1) HRP20170171T1 (enExample)
HU (1) HUE031679T2 (enExample)
MX (1) MX360783B (enExample)
PL (1) PL2882723T3 (enExample)
PT (1) PT2882723T (enExample)
SI (1) SI2882723T1 (enExample)
WO (1) WO2014023623A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105801500B (zh) * 2014-12-31 2018-08-24 四川科伦药物研究院有限公司 拆分艾沙康唑中间化合物消旋体的方法
CN106317044A (zh) * 2015-06-30 2017-01-11 刘玫君 一种制造艾沙康唑或雷夫康唑的方法
CN104961695A (zh) * 2015-07-27 2015-10-07 成都塞恩斯医药科技有限公司 一种艾沙康唑和雷夫康唑中间体的制备方法
CN106467534B (zh) * 2015-08-17 2019-10-11 江苏奥赛康药业有限公司 一种硫酸艾沙康唑鎓化合物及其药物组合物
CN105907832B (zh) * 2015-12-02 2019-07-12 成都师范学院 一种酶法拆分艾沙康唑中间体的方法
CN108452848B (zh) * 2016-02-24 2020-12-11 上海兰立生物科技有限公司 一种催化剂
WO2018200214A2 (en) * 2017-04-27 2018-11-01 Codexis, Inc. Ketoreductase polypeptides and polynucleotides
WO2021245590A1 (en) * 2020-06-04 2021-12-09 Metrochem Api Private Limited An improved process for the preparation of triazole derivatives
CN111574444A (zh) * 2020-07-07 2020-08-25 安徽贝克生物制药有限公司 一种贝达喹啉的制备方法
CN116478103B (zh) * 2023-03-24 2025-07-25 四川澄华生物科技有限公司 一种拆分艾沙康唑中间体4的方法
CN119661453B (zh) * 2025-02-17 2025-04-22 四川澄华生物科技有限公司 一种制备艾沙康唑的主链中间体的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8510195D0 (en) * 1985-04-22 1985-05-30 Ici Plc Heterocyclic compounds
US5134152A (en) 1989-12-07 1992-07-28 Sankyo Company, Limited Oxetane derivatives and their use as anti-fungal or fungicidal agents
JP2887523B2 (ja) * 1990-11-30 1999-04-26 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩
GB9107055D0 (en) * 1991-04-04 1991-05-22 Pfizer Ltd Triazole antifungal agents
JP4208269B2 (ja) * 1996-10-01 2009-01-14 東芝ソリューション株式会社 異種物混入検査方法及びそのシステム
AU7937998A (en) 1997-07-08 1999-02-08 Sankyo Company Limited Antifungal triazole compounds
WO1999045008A1 (en) 1998-03-06 1999-09-10 F. Hoffmann-La Roche Ag 3-[4-(4-cyanophenyl)thiazol-2-y)]-1-(1h-1,2,4-triazol-1-yl)-butan-2-ol derivatives having antifungal activity
MXPA03010914A (es) 2001-06-26 2004-02-17 Basilea Pharmaceutica Ag DERIVADOS DE HALOFENILO INTERMEDIARIOS Y SU USO EN UN PROCESO PARA LA PREPARACIoN DE DERIVADOS DE AZOL.
WO2007062542A2 (en) 2005-12-01 2007-06-07 Basilea Pharmaceutica Ag Process for the manufacture of epoxybutanol intermediates
GB0712972D0 (en) 2007-07-04 2007-08-15 Glaxosmithkline Consumer Healt Formulation
ES2652559T3 (es) 2007-07-04 2018-02-05 Dpx Holdings B.V. Preparación de una esterasa
CN102344457B (zh) 2007-09-12 2015-07-22 杏林制药株式会社 作为 gsk-3 抑制剂的螺环状氨基喹诺酮
EP2289868B1 (en) 2008-06-25 2014-08-13 Daiichi Sankyo Company, Limited Carboxylic acid compound
SI2298747T1 (sl) * 2008-07-03 2017-08-31 Astellas Pharma Inc. Derivat triazola ali njegova sol
US8921080B2 (en) 2009-04-24 2014-12-30 Dsm Ip Assets B.V. Pig liver esterases
US8207352B2 (en) * 2009-10-08 2012-06-26 Drug Process Licensing Associates LLC Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole
WO2011145669A1 (ja) * 2010-05-19 2011-11-24 大日本住友製薬株式会社 アミド誘導体

Also Published As

Publication number Publication date
JP6334529B2 (ja) 2018-05-30
KR20150037875A (ko) 2015-04-08
CA2878361A1 (en) 2014-02-13
CN104507917A (zh) 2015-04-08
PT2882723T (pt) 2017-02-23
EP2882723A1 (en) 2015-06-17
WO2014023623A1 (en) 2014-02-13
KR102129150B1 (ko) 2020-07-02
CN104507917B (zh) 2017-10-17
ES2616412T3 (es) 2017-06-13
US20150239852A1 (en) 2015-08-27
US9783508B2 (en) 2017-10-10
BR112015002526A2 (pt) 2018-06-12
MX2015000744A (es) 2015-04-14
US20190077771A1 (en) 2019-03-14
EP2882723B1 (en) 2016-11-16
MX360783B (es) 2018-11-16
JP2015527345A (ja) 2015-09-17
BR112015002526B1 (pt) 2022-09-06
CA2878361C (en) 2020-09-22
PL2882723T3 (pl) 2017-05-31
SI2882723T1 (sl) 2017-04-26
HUE031679T2 (en) 2017-07-28
US10590092B2 (en) 2020-03-17

Similar Documents

Publication Publication Date Title
HRP20170171T1 (hr) Postupak za proizvodnju isavukonazola ili ravukonazola
HRP20181818T1 (hr) Postupak za proizvodnju supstituiranih 5-fluoro-1h-pirazolopiridina
SMT201700130B (it) Diidratodicomposto di benzotiofeneeprocessoper la produzione dello stesso
HUE037048T2 (hu) Eljárások 4-cikloalkiloxibenzolszulfonamidok elõállítására
HRP20181227T1 (hr) Metode za liječenje atopijskog dermatitisa primjenom antagonista il-4r
HRP20181628T1 (hr) Spojevi i postupci za njihovu upotrebu
DK2895156T3 (da) Fremgangsmåde til fremstilling af terapeutiske nanopartikler
DK2834236T3 (da) Heterocyclylforbindelser
HUE042664T2 (hu) 2-Helyettesített cefem-vegyületek
SI2953904T1 (sl) Postopek za nadzorovanje izdelave biocida
PL2819853T3 (pl) Sposób wytwarzania polimerów dienowych
IL231351A0 (en) Amino-substituted imidazopyridazines
DK3210978T3 (da) Fremgangsmåde til fremstilling af acesulfamkalium
AR092198A1 (es) Derivados de pirazolopirimidinas
HRP20150187T1 (xx) Makrocikliäśki spojevi i postupci za njihovu proizvodnju
HRP20181747T1 (hr) Postupak za selektivnu proizvodnju n-metil-para-anisidina
IL236668A0 (en) Production method of solid surfaces for construction
HRP20181122T1 (hr) Postupak za pripremu jopamidola
HRP20182168T1 (hr) Postupak za proizvodnju građevne ploče
HRP20190229T1 (hr) Ormar, postupak za izradu ormara
FR2995231B1 (fr) Procede de trefilage
HRP20181805T1 (hr) Postupak za proizvodnju poligvanidina
ES1080381Y (es) Fachada de medios
PL2883461T3 (pl) Sposób wytwarzania aktywnej folistatyny
EP2842958A4 (en) NAPHTHOBISTHIADIAZOLDERIVAT